Since SETD6 associates with nuclear receptor signaling-associated factors and ERα, we investigated the expression of known estrogen-responsive genes by qPCR in control and SETD6-depleted breast carcinoma cell lines. The gene discussed is SETD6; the disease is breast carcinoma.